Primary |
Chronic Myeloid Leukaemia |
68.0% |
Hypertension |
7.3% |
Prophylaxis |
4.8% |
Gastrointestinal Stromal Tumour |
3.7% |
Diabetes Mellitus |
2.2% |
Pain |
1.8% |
Acute Lymphocytic Leukaemia |
1.4% |
Coronary Artery Disease |
1.0% |
Leukaemia |
1.0% |
Depression |
1.0% |
Hypercholesterolaemia |
1.0% |
Hypothyroidism |
1.0% |
Neoplasm Malignant |
0.9% |
Constipation |
0.9% |
Nausea |
0.7% |
Hyperlipidaemia |
0.7% |
Insomnia |
0.6% |
Dyspepsia |
0.6% |
Hyperuricaemia |
0.6% |
Atrial Fibrillation |
0.6% |
|
Death |
19.1% |
Electrocardiogram Qt Prolonged |
9.6% |
Rash |
8.7% |
Myocardial Infarction |
6.7% |
Vomiting |
6.6% |
Thrombocytopenia |
6.0% |
Weight Decreased |
3.8% |
White Blood Cell Count Decreased |
3.7% |
Nausea |
3.6% |
Pruritus |
3.6% |
Pyrexia |
3.6% |
Neoplasm Malignant |
3.1% |
Platelet Count Decreased |
3.1% |
Dyspnoea |
2.8% |
Fatigue |
2.8% |
Pneumonia |
2.8% |
Cerebrovascular Accident |
2.7% |
Pancreatitis |
2.7% |
Pain |
2.6% |
Headache |
2.5% |
|
Secondary |
Chronic Myeloid Leukaemia |
52.7% |
Prophylaxis |
10.9% |
Hypertension |
8.1% |
Diabetes Mellitus |
4.6% |
Gastrointestinal Stromal Tumour |
3.0% |
Constipation |
2.6% |
Pain |
2.1% |
Coronary Artery Disease |
2.1% |
Rheumatoid Arthritis |
1.9% |
Hyperlipidaemia |
1.6% |
Insomnia |
1.3% |
Hypothyroidism |
1.2% |
Acute Myeloid Leukaemia |
1.2% |
Dyspepsia |
1.2% |
Atrial Fibrillation |
1.1% |
Hyperuricaemia |
1.0% |
Dry Eye |
0.9% |
Nasopharyngitis |
0.9% |
Depression |
0.8% |
Nausea |
0.8% |
|
White Blood Cell Count Decreased |
11.2% |
Electrocardiogram Qt Prolonged |
10.7% |
Thrombocytopenia |
8.4% |
Rash |
7.1% |
Platelet Count Decreased |
6.4% |
Vascular Graft |
6.0% |
Pyrexia |
5.4% |
Vomiting |
5.3% |
Pulmonary Oedema |
3.7% |
Weight Increased |
3.5% |
Coronary Artery Disease |
3.4% |
Weight Decreased |
3.4% |
White Blood Cell Count Increased |
3.4% |
Stent Placement |
3.3% |
Ventricular Extrasystoles |
3.3% |
Fatigue |
3.2% |
Malaise |
3.1% |
Myocardial Infarction |
3.1% |
Uterine Cancer |
3.0% |
Incorrect Dose Administered |
2.9% |
|
Concomitant |
Product Used For Unknown Indication |
28.2% |
Chronic Myeloid Leukaemia |
27.5% |
Leukaemia |
5.3% |
Prophylaxis |
4.6% |
Prophylaxis Against Graft Versus Host Disease |
4.6% |
Acute Lymphocytic Leukaemia |
3.8% |
Antiviral Prophylaxis |
3.1% |
Bone Marrow Conditioning Regimen |
2.3% |
Hypertension |
2.3% |
Nervous System Disorder |
2.3% |
Paroxysmal Nocturnal Haemoglobinuria |
2.3% |
Antifungal Prophylaxis |
1.5% |
Arthritis |
1.5% |
Drug Intolerance |
1.5% |
Fungal Infection |
1.5% |
Graft Versus Host Disease In Intestine |
1.5% |
Hiv Infection |
1.5% |
Hyperuricaemia |
1.5% |
Hypothyroidism |
1.5% |
Immunosuppressant Drug Therapy |
1.5% |
|
Dyspnoea |
6.7% |
Fatigue |
6.7% |
Myalgia |
6.7% |
Myocardial Infarction |
6.7% |
Off Label Use |
6.7% |
Pleural Effusion |
6.7% |
Polypectomy |
6.7% |
Rash |
6.7% |
Tachycardia |
6.7% |
White Blood Cell Count Increased |
6.7% |
Arachnoiditis |
3.3% |
Balance Disorder |
3.3% |
Basal Cell Carcinoma |
3.3% |
Blood Creatinine Increased |
3.3% |
Blood Urine Present |
3.3% |
Cardiac Failure Congestive |
3.3% |
Chest Pain |
3.3% |
Chronic Myeloid Leukaemia |
3.3% |
Convulsion |
3.3% |
Decreased Appetite |
3.3% |
|
Interacting |
Chronic Myeloid Leukaemia |
49.4% |
Arrhythmia |
7.4% |
Gastrooesophageal Reflux Disease |
4.9% |
Hypertension |
4.9% |
Diabetes Mellitus |
3.7% |
Acute Lymphocytic Leukaemia |
2.5% |
Atrial Fibrillation |
2.5% |
Chromosome Analysis Abnormal |
2.5% |
Epididymitis |
2.5% |
Hypercholesterolaemia |
2.5% |
Hyperuricaemia |
2.5% |
Neuropathy Peripheral |
2.5% |
Oesophagitis |
2.5% |
Product Used For Unknown Indication |
2.5% |
Antacid Therapy |
1.2% |
Blood Pressure |
1.2% |
Myeloproliferative Disorder |
1.2% |
Oedema |
1.2% |
Parkinson's Disease |
1.2% |
Pneumonia Bacterial |
1.2% |
|
Drug Interaction |
25.8% |
Electrocardiogram Qt Prolonged |
12.9% |
Asthenia |
6.5% |
Atrial Flutter |
6.5% |
Myalgia |
6.5% |
Cardiac Failure |
3.2% |
Convulsion |
3.2% |
Coronary Artery Disease |
3.2% |
Fluid Retention |
3.2% |
Gingivitis |
3.2% |
Headache |
3.2% |
Nasal Congestion |
3.2% |
Nausea |
3.2% |
Oedema Peripheral |
3.2% |
Pancreatitis |
3.2% |
Sepsis |
3.2% |
Therapeutic Response Decreased |
3.2% |
Visual Acuity Reduced |
3.2% |
|